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Prevalence, clinical profile, cause of hospitaliza-
tion and outcomes in patients with left bundle
branch block in the state of Qatar
Fahad Alkindi, Abulrahman Arabi, Ashfaq Patel,
Rajvir Singh, Jassim Alswaidi, Hajar A. Hajar
Albinali
Objectives: We studied the prevalence, clinical char-
acteristics, management and outcome among patients
with LBBB hospitalized in the cardiology department.
Methods: Retrospective analysis of the 22-year regis-
try data (Jan 1991 to Jun 2012) of cardiac patients hospital-
ized at Hamad General Hospital and Qatar Heart
Hospital, Doha, Qatar.
Results: Of the 41438 patients admitted under cardi-
ology department, 582 patients had LBBB (1.4%). Com-
pared to patients without LBBB, LBBB patients were
older (63 ± 12 vs. 54 ± 12 ears, P = 0.001), more likely to
be female (33 vs.23%, P = 0.001) and to be middle east-
ern(76.5 vs. 54%). LBBB patients have more hypertension
(56 vs. 40%, P = 0.001), Diabetes (52% vs. 39%, P = 0.004)
and chronic renal failure (11% vs.4%, P = 0.001),but less
likely to be current smoker (16% vs. 23%, P = 0.001).
CHF was the most common cause of admission in LBBB
(40% vs. 17% in no LBBB patients, P = 0.001), followed
by unstable angina (35 vs. 40%, P = 0.03) and myocardial
infarction (9.3 vs. 23%). In hospital mortality was signifi-
cantly higher in LBBB patients (8% vs. 4.7%, P = 0.001).
Conclusion: Patients with LBBB are more likely to
admitted with CHF, and less likely to be admitted with
acute coronary syndrome as compared to patients with-
out LBBB. Moreover LBBB is associated with a 2-folds
increase in mortality as compared to those without
LBBB.
http://dx.doi:10.1016/j.jsha.2013.03.068
Long term follow up of permanent pacing in
children
Fahad A. Al-Muqbil, Majid Al Fayyadh, Nuha
Al-Hefdhi, Abdulah Al-Wadai, Waleed Al-Manea,
Zuhair Al-Halees
Objective: To evaluate the experience and the long-
term results of pacemaker (PM) therapy in children.
Methods: We performed a retrospective analysis of
all patients (pts) who underwent PM implantation at
King Faisal Heart Institute. Data obtained include: demo-
graphics, diagnosis, indication for pacing, and follow up
evaluation.
Results: Between 1985 and 2012, 516 pts had PMs
implanted; mean age is 2.4 years (2days–18 years). The
most frequent indication are: surgical AV block 392 pts
(76%), congenital AV block 73 pts (14%), sinus node dys-
function 38 pts (7%). Surgical AV block was encountered
after relieve of left ventricular outflow tract obstruction,
ventricular septal defect (VSD) repair, and repair of com-
plex lesion associated with ventricular inversion. Con-
genital AV block was isolated in 58 pts; the remaining
had associated congenital heart defects (ventricular
inversion 10, VSD 2, coarctation 2, truncus arteriosus 1).
The initial PM system was epicardial in 412 pts (80%).
After a mean follow up of 4.2 years (1 month–25 years),
105 pts had 159 revision procedures (lead malfunction
73, battery depletion 77, PM infection 9). Lead malfunc-
tion was more encountered with epicardial leads. There
was no mortality directly related to the PM implantation
procedure or function however there were 21 pts lost
during the follow up and 14 pts (3%) had nonpacemaker
related death.
Conclusion: Pacemakers are safe and effective ther-
apy in children. Epicardial lead malfunction is a frequent
reason for pacemaker revision.
http://dx.doi:10.1016/j.jsha.2013.03.069
Transcatheter aortic valve implantation: Single
center experience with mid-term follow-up
Feras Khaliel, Zohair Alhalees, Salman Alarfaj,
Hani Alsergani, Maie Shahed, Jehad Alburaiki
Background: Transcatheter aortic-valve implanta-
tion (TAVI) is an emerging intervention for the treatment
of high-risk patients with severe aortic stenosis and coex-
isting illnesses.
Methods: Between August 2009 and May 2012, we
have conducted a retrospective study underwent a bal-
loon expandable transcatheter xenograft (Edwards SAP-
IEN) and evaluated the intermediate-term all cause
mortality. Average STS and EuroSCORE II predicted risk
for mortality was 18.4 ± 8.9% and 7.6 ± 5.5%, respectively.
The end points included feasibility, safety, efficacy, and
durability.
Results: A total of 27 consecutive patients underwent
TAVI. Nine (33.3%) patients among them had it through
the trans-apical approach. The mean age was 76 ± 8
years; 41% of the patients were females. There was
100% successful implantation. Hospital and one-year
mortality were 2 (7.4%) and 4 (14.8%), respectively. At 1
year, the incidence of stroke was 1 (3.7%), infection 6
(22%), AV block 2 (7.4%), severe bleeding 2 (7.4%), vascu-
lar complication (14.8%), and the incidence of peripros-
thetic aortic regurgitation (<2) was 5 (18.5%). No patient
been converted to open surgery. There was a significant
improvement of patient left ventricular function post
TAVI (p = 0.001), and of aortic valve area (AVA) with
mean 0.4 ± 01cm2 ranging from 0.2 to 0.9 cm2 pre-and
1 ± 0.3 cm2 ranging from 1 to1.9 cm2 post-TAVI
(p = 0.0001). The aortic pressure gradients have improved
significantly from 45 ± 11 mm Hg pre-to 8.5± 5.5 mm Hg
post-implantation (p = 0.0001). For all patients the aver-
age length of follow-up by echocardiography was 346
days and was 100% completed.
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Conclusions: TAVI has provided good results in the
initial 27 patients. However, The use of transcatheter aor-
tic valve implantation should be restricted to the inoper-
able high-risk patients.
http://dx.doi:10.1016/j.jsha.2013.03.071
Downs syndrome and cardiac surgery, a dilemma,
should we operate or not?
Ghada Shiekh Abdullah, Shehla Jadoon,
Milad Elsegaier, M.O. Galal
Background: Incidence of congenital heart disease
in patients with Down syndrome (DS) is 40%. In the
past some have advocated that the cardiac defects in
DS should not be repaired, reports had shown outcome
comparable to individuals without DS. The aim of the
study is to analyze the outcome of cardiac surgery in
DS.
Methodology: We conducted a retrospective study
in the last 2 years at our institution. Patients involved
were DS less than 13 years who had cardiac surgery.
DS with chronic lung disease or unreactive pulmonary
hypertension were excluded. We analyzed their demo-
graphic data, cardiac lesion, type of surgery, ICU stay,
morbidities and mortality.
Results: 23 patients with DS (11 Females, 13 Males),
with median age of 7 months, mean age of 32month.
AVSD were (n = 15) 65%), VSD were (n = 5) 21%. Postop-
eratively, 21% were extubated on the same day. 27% had
intubation more than 9 days. Almost 30% had a hospital
stay of >15 days. Complications were respiratory prob-
lems in 45%, arrhythmias in 8% and residual AV valve
regurgitation in 8%. Hospital mortality was (n = 2/23) 8%.
Conclusion: Whether to operate Down syndrome
patients or not remains unclear. Our study showed, sig-
nificant postoperative complications, lengthy hospital
stay and relatively high mortality. Despite of this we feel
they should be given the chance of surgery to improve
their life quality.
http://dx.doi:10.1016/j.jsha.2013.03.072
Utilization of prophylactic drug therapy after acute
myocardial infarction in Abu Dhabi and Sweden
Oliver Harrison, Khaled Aidha Al Jaberi, Eman S.
Hassan, Björn Wettermark, Ana-Marija Gjurovic,
Gunnar Engström
Purpose: Pharmaceutical treatments to decrease
blood pressure and lipids, inhibit platelet aggregation,
and control diabetes are cornerstones of secondary pre-
vention after acute myocardial infarction (AMI). This
study compares the drug use during a oneyear period
post-AMI in Abu Dhabi and Sweden.
Methods: In Abu Dhabi, information on medications
dispensed during one year following a hospitalized AMI
during January 2010 to June 2011 (n = 1,326) was retrieved
from the Health Authority of Abu Dhabi’s administrative
claims database. Rates of at least one prescription within
selected classes were quantified immediately following
the event (months 0–3), 4–6 months, and 10–12 months
after the event. Similar data was collected for hospital-
ized AMI patients in Sweden during 2009 (n = 19,312),
by linkage of the Swedish Myocardial Infarction register
and Prescribed Drug Register. All proportions were age-
standardized.
Results: During the first three months post-AMI, the
proportion of patients in Abu Dhabi with at least one pre-
scription of an anti-hypertensive drug was 76%, statin
72%, platelet aggregator inhibitor 76%, beta-blocker
64%, and drugs affecting the renin-angiotensin system
only 56%. These proportions declined to 36%, 34%, 34%,
28% and 28%, respectively, during month 10-12. Reduc-
tions among UAE citizens were somewhat lower than
among expatriates. In Sweden, the corresponding pro-
portions were 90%, 82%, 89%, 83% and 68%, respectively,
10- 12 months post-AMI.
Conclusion: Abu Dhabi’s health data systems offer a
valuable tool for monitoring adherence to drug use. It
appears that the outcomes of AMI patients in Abu Dhabi
could be substantially improved by promoting adherence
to evidence-based guidelines for secondary prevention.
http://dx.doi:10.1016/j.jsha.2013.03.073
Systemic lupus erythrematosus; its implication in
cardiac surgery: Institutional case report
Hala Samir El-Mohamady ⇑
Introduction: Systemic lupus erythematosus (SLE)
is an autoimmune disease that primarily affects young
women. According to the literature, the prevalence of
cardiovascular involvement in patients with systemic
lupus erythematosus (SLE) has been estimated to be
more than 50%.
Valvular involvement is the most frequent cardiac
manifestation in SLE. Functionally, valvular regurgitation
hasbeen reported to occur in up to 74% of patients.
Meanwhile valvular endocarditis is a frequent manifesta-
tion of SLE, and the mitral valve is most frequently
affected. However, any valve or multivalvular affection
may occur.
Valvular lesions resulting from lupus can cause severe
mitral regurgitation (MR). The most classic cardiac
valvular abnormality in patientswith SLE is known as
Libman–Sacks endocarditis, which consists of
noninfective, verrucousvegetations(marantic endocardi-
tis). They occur most frequently onthe mitral valve. Most
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